OKYO Pharma Announces Purchase of Shares by Chairman
OKYO Pharma Limited announced that its Chairman, Mr. Gabriele Cerrone, has acquired an additional 25,000 shares, increasing his ownership to 20.51%, demonstrating strong insider confidence. The company is preparing to start a global Phase 3 pivotal clinical trial for its lead drug candidate, urcosimod, targeting neuropathic corneal pain.